| 6ACB: reference: Optimization of Chromeno[2,3- c]pyrrol-9(2 H)-ones as Highly Potent, Selective, and Orally Bioavailable PDE5 Inhibitors: Structure-Activity Relationship, X-ray Crystal Structure, and Pharmacodynamic Effect on Pulmonary Arterial Hypertension., Wu D, Huang Y, Chen Y, Huang YY, Geng H, Zhang T, Zhang C, Li Z, Guo L, Chen J, Luo HB, J Med Chem. 2018 Sep 7. doi: 10.1021/acs.jmedchem.8b01209. PMID: 30148362 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).